MK-1496

MK-1496 is an orally active and highly selective PLK1 inhibitor. MK-1496 exerts antitumor effects by inducing G2/M phase arrest and apoptosis in tumor cells. MK-1496 can be used in research related to parotid gland carcinoma and small cell lung cancer.

For research use only. We do not sell to patients.

  • CAS No.: 1037254-47-9
  • Formula: C14H24N2O
  • Molecular Weight:236.35
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs

All Polo-like Kinase (PLK) Isoforms

More
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00